Vejon COVID-19 Review

Vejon COVID-19 Review

Share this post

Vejon COVID-19 Review
Vejon COVID-19 Review
Autoantibodies to Angiotensin II in COVID-19

Autoantibodies to Angiotensin II in COVID-19

Dr Philip McMillan's avatar
Dr Philip McMillan
Dec 30, 2021
∙ Paid

Share this post

Vejon COVID-19 Review
Vejon COVID-19 Review
Autoantibodies to Angiotensin II in COVID-19
Share
No alternative text description for this image

Understanding the science around autoimmunity in COVID-19 will open the door to strategies that reduce the risk of severe COVID-19 and long covid. The scientific community has been slow to change direction but it comes with a cost to human lives.

This pre-print paper has found autoantibodies to angiotensin II to be significantly higher in severe COVID-19…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Philip McMillan
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share